Nestled in the rolling hills of southeastern Ventura County, and 30 miles from downtown LA, Simi Valley embodies California charm.
Residents and visitors alike love Simi Valley for its distinct small-town vibe and easy access to all the urban attractions of Southern California’s biggest cities.
But for those living with depression, enjoying all that Simi Valley has to offer isn’t always easy.
Which is why we’ve opened Achieve TMS Simi Valley.
Our depression treatment center distinctly offers the revolutionary dTMS therapy (deep transcranial magnetic stimulation). FDA-approved, TMS therapy is a highly effective form of depression treatment that delivers a series of short magnetic pulses to the limbic system of mood center of the brain.
As the country’s largest TMS treatment providers, we’ve helped more than 600 patients free themselves from the pain of depression.
Transcranial magnetic stimulation is free of drugs or anesthesia, our short 20 minute TMS treatments give you the powerful but quick treatment you need to get on with your day.
TMS Treatments are pain-free and many patients begin to see results within as little as two weeks.*
Achieve TMS is America’s largest provider of deep TMS therapy for the treatment for depression. Stop the despair. Take the next step. Regain joy.
Give us a call at 877-447-6503 for a free consultation or email us at email@example.com to learn more.
Please use ER or call 911 for emergency and contact your insurance provider for additional resources and contacts for covered providers.
So far, within California, Transcranial Magnetic Stimulation has been approved for use in treatment-resistant depression by Anthem Blue Cross/ Blue Shield, Humana, United Health Care, Healthnet, Tricare and more. Please call us for a list of providers. We would be happy to help check with your insurance provider regarding pre-approval.
*Different people with various diagnoses are helped to differing degrees. Results vary. Official FDA Approval is currently restricted to depression but several other uses are awaiting approval.